Indexed with PubMed and Science Citation Index (E) 
Users online: 5251 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal


Year : 2002  |  Volume : 68  |  Issue : 5  |  Page : 272-

Oral rifampicin in cases of cutaneous leishmaniasis with multiple lesions (A pilot study)

Department of Skin, V.D. & Leprosy, S.P Medical College & A.G. of Hospitals, Bikaner-334 003, India

Correspondence Address:
R A Bumb
H-3, PBM Hospital Campus, Bikaner-334 003
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 17656965

Rights and PermissionsRights and Permissions

The multiple lesions of cutaneous leishmaniasis (CL) require an effective oral agent. We are reporting a pilot study of oral rifampicin 600 mg. bid or 20 mg/kg. body weight in cases of CL with multiple lesions. Our study shows 83.3% parasitological and clinical cure with insignificant side effects after 4 weeks of therapy. No relapse upto 6 months of completion of study was seen.

[FULL TEXT] [PDF Not available]*

Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow